Hrt Financial LP Sensei Biotherapeutics, Inc. Transaction History
Hrt Financial LP
- $15.7 Billion
- Q4 2024
A detailed history of Hrt Financial LP transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 11,600 shares of SNSE stock, worth $5,568. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600Holding current value
$5,568% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNSE
# of Institutions
26Shares Held
2.39MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$311,9820.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$285,3370.0% of portfolio
-
Catalio Capital Management, LP New York, NY294KShares$141,2990.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$82,9430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$75,2640.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.7M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...